Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjiang Pharmaceutical is a pioneer and leader in the modernization of Traditional Chinese Medicine (TCM), specifically specializing in the research and production of TCM formula granules. Founded in 1992 and headquartered in Jiangyin, China, it was the first enterprise to receive state approval for the pilot production of concentrated herbal extracts. The company offers a comprehensive portfolio of over 700 varieties of single-herb granules, which are standardized to replace traditional raw decoctions in clinical settings. As a core subsidiary of China Traditional Chinese Medicine Holdings (under the Sinopharm group), Tianjiang maintains high-level GMP manufacturing facilities and advanced quality control technologies such as fingerprint chromatography. Its products are widely utilized in thousands of hospitals across China and exported to international markets including North America and Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Jiangyin Tianjiang Pharmaceutical.